Page last updated: 2024-08-24

cidofovir anhydrous and dichlororibofuranosylbenzimidazole

cidofovir anhydrous has been researched along with dichlororibofuranosylbenzimidazole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Blumberg, EA; Halpern-Cohen, V1

Reviews

1 review(s) available for cidofovir anhydrous and dichlororibofuranosylbenzimidazole

ArticleYear
New Perspectives on Antimicrobial Agents: Maribavir.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Adult; Anti-Infective Agents; Antiviral Agents; Benzimidazoles; Child; Cidofovir; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir

2022